GLP-1 receptor agonists approved for use in the UK include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia)
Now, just months after these blockbuster weight-loss medications entered the Indian market, obstetricians and gynaecologists across major cities are noticing a quiet but striking trend
Follow-Ups That Fit: Well see you regularly (in-office or virtual) to monitor progress and adjust the plan
Conclusion Active GLP-1 is a gut hormone derived as a result of proglucagon processing 1,2
tirzepatide has not been studied in patients with a history of pancreatitis, and alternative therapy should be considered in these individuals Gallbladder disease : Rapid weight loss increases cholelithiasis risk